SCHEMBL885673

SCHEMBL885673

O=C(O)N1CCN(C(=O)c2[nH]c(=O)n(-c3ccccc3)c2-c2ccc(Cl)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
PTGS2 P35354 1/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.42
KMT2A Q03164 6/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MGLL Q99685 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2063853 0.92 ALDH1A1 (0.42) ALDH1A1LMNAKMT2AMEN1L3MBTL1
SCHEMBL2062757 0.90 SCN5A (0.46) ALOX5PTGS2ALDH1A1LMNAKMT2A
SCHEMBL885971 0.89 ALDH1A1 (0.47) ALOX5PTGS2ALDH1A1LMNAKMT2A
SCHEMBL8171812 0.85 KMT2A (0.50) ALOX5PTGS2LMNAKMT2AMEN1
SCHEMBL885974 0.84 LMNA (0.40) ALOX5PTGS2ALDH1A1LMNAKMT2A
SCHEMBL885777 0.82 KMT2A (0.48) ALDH1A1LMNAKMT2AMEN1L3MBTL1
SCHEMBL2063138 0.81 SIGMAR1 (0.49) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL885507 0.79 CYP1A2 (0.47) ALOX5PTGS2ALDH1A1CYP1A2CYP3A4
SCHEMBL885925 0.77 GABRA2 (0.50) ALOX5ALDH1A1LMNAKMT2AMEN1
SCHEMBL8171807 0.76 USP30 (0.47) KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO claimed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 US disclosed
WO-2008089005-A2 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105665-A1 RENIN INHIBITORS REN, ACE, AGT ALOX5 970/4885PTGS2 686/4885ALDH1A1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.